Organization :   Cancer Molecular Diagnostics, St. James’s Hospital, Dublin D08 E9P6, Ireland

2526_330Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
Authors :Langabeer S.E.* Haslam K. Crampe M. MacDonagh B.... Date: 2019-03-26 / Views: 421
The JAK2 V617F mutation in lung cancer: caveat emptor
Author :Langabeer S.E.* Date: 2018-12-27 / Views: 971
Anagrelide and the CALR mutation allele burden in essential thrombocythemia
Authors :Atkinson E. Bakri M. Hayat A. Langabeer S.E.* Date: 2018-06-27 / Views: 626